↓ Skip to main content

Megestrol acetate for treatment of anorexia-cachexia syndrome

Overview of attention for article published in this source, April 2005
Altmetric Badge

Mentioned by

twitter
5 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
182 Dimensions

Readers on

mendeley
71 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Megestrol acetate for treatment of anorexia-cachexia syndrome
Published by
John Wiley & Sons, Ltd, April 2005
DOI 10.1002/14651858.cd004310.pub2
Pubmed ID
Authors

Berenstein, Graciela, Ortiz, Zulma

Abstract

Megestrol acetate (MA) is currently used to improve appetite and to increase weight in cancer-associated anorexia. In 1993 MA was approved by the USA's Federal Drug Administration for the treatment of anorexia, cachexia, or unexplained weight loss in patients with AIDS. The mechanism by which MA increases appetite is unknown, and its effectiveness for anorexia and cachexia in neoplastic and AIDS patients is under investigation.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Hong Kong 1 1%
Canada 1 1%
Unknown 69 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 17%
Researcher 10 14%
Student > Ph. D. Student 8 11%
Student > Bachelor 7 10%
Student > Postgraduate 6 8%
Other 13 18%
Unknown 15 21%
Readers by discipline Count As %
Medicine and Dentistry 26 37%
Nursing and Health Professions 6 8%
Psychology 5 7%
Agricultural and Biological Sciences 3 4%
Biochemistry, Genetics and Molecular Biology 3 4%
Other 6 8%
Unknown 22 31%